Pharma channel feed

White House seeks $65B to pre­pare for fu­ture pan­demics in 'Apol­lo'-like ef­fort

4 years ago
Coronavirus

Eli Lil­ly sued by for­mer em­ploy­ees al­leg­ing age dis­crim­i­na­tion, cit­ing hir­ing prac­tices fa­vor­ing in­terns

4 years ago

Sack­lers win im­mu­ni­ty from opi­oid law­suits as Pur­due Phar­ma is dis­solved in bank­rupt­cy set­tle­ment

4 years ago
People

FDA ap­proves BeiGene's Brukin­sa in rare blood can­cer amid com­pa­ny's US ex­pan­sion plans

4 years ago
FDA+

Scoop: In­spired by the late Tachi Ya­ma­da, Jim Wil­son launch­es new non­prof­it tar­get­ing un­der­served ul­tra-rare dis­eases

4 years ago
People

Ab­b­Vie's stock and next megablock­buster take hits fol­low­ing new JAK warn­ings from FDA

4 years ago
FDA+

An FTC re­view of the Sanofi/Trans­late merg­er has a new dead­line af­ter agency calls for more time

4 years ago
Deals

With drug pric­ing re­form po­ten­tial­ly clos­er than ever, Pub­lic Cit­i­zen pens new let­ter call­ing for change

4 years ago

FDA ex­tends full ap­proval for Mer­ck­'s Keytru­da in 1st-line blad­der can­cer af­ter mixed ad­comm vote

4 years ago
FDA+

A jog down mem­o­ry lane: How many times have De­moc­rats tried and failed to win drug price ne­go­ti­a­tions?

4 years ago

Re­im­burse­ment be­gins slow­ly for Bio­gen’s ex­pen­sive Alzheimer’s drug

4 years ago

Founders of Tai­wanese biotech in­volved in steal­ing Genen­tech se­crets plead guilty to con­spir­a­cy

4 years ago
People

Sanofi, Re­gen­eron bur­nish their block­buster Dupix­ent fran­chise with pos­i­tive re­sults in chil­dren with un­con­trolled eczema

4 years ago
R&D

Bank­rupt­cy judge: J&J can spin talc pow­der in­to dif­fer­ent com­pa­ny, po­ten­tial­ly slow­ing plain­tiff­s' pay­outs

4 years ago

Ap­peals court sides with Gilead, Kite in CAR-T patent brawl, void­ing Bris­tol My­ers’ big $1.2B award

4 years ago
Cell/Gene Tx

CBO warns of al­most 60 few­er new drugs over three decades with Medicare drug ne­go­ti­a­tions bill

4 years ago

Mer­ck­'s 15-strain pneu­mo­nia shot match­es Pre­vnar 13 in late-stage in­fant study, but Pfiz­er's next-gen shot looms

4 years ago
R&D

Re­gen­eron earns mid-stage win for high­er dose of Eylea, hop­ing to re­fresh its sales pitch

4 years ago
R&D

Cara, Vi­for Phar­ma score speedy FDA nod on itch­ing drug for CKD — shares surge

4 years ago
FDA+

De­lay­ing the in­evitable? Ax­some says FDA re­view go­ing be­yond PDU­FA date

4 years ago
FDA+

Court up­holds Ab­b­Vie's patents on block­buster can­cer drug Im­bru­vi­ca, gener­ics un­like­ly un­til 2032

4 years ago

House com­mit­tee ques­tions Eli Lil­ly, Sanofi and No­vo Nordisk as in­sulin prices re­main 'u­nac­cept­ably high'

4 years ago

J&J's Alex Gorsky set to step away from CEO role, hand­ing the reins to Covid-19 czar Joaquin Du­a­to

4 years ago
People

UK's cost-ef­fec­tive­ness gate­keep­er wants to pro­vide faster ac­cess to more new drugs

4 years ago
R&D
First page Previous page 233234235236237238239 Next page Last page
A service from the Financial Times